arises from an ongoing Phase 1 tria...

arises from an ongoing Phase 1 trial of APC8024 (Dendreon Corporation, Seattle, WA), a therapeutic vaccine for breast, colon and ovarian cancer, indicate the fruit is well tolerated, stimulates T-cell immunity, and is continuing to exhibit to clinical benefit in subjects with advanced, metastatic HER2-positive breast cancer. Four make submissives demonstrated a partial